Rochell Issa (she/her)

Optimization of Postpartum Care for Patients With & at Risk for Premature & Long-Term CVD: ACC Expert Consensus Decision Pathway jacc.org/doi/10.1016/j.… @JACCJournals @ACCinTouch @DrKLindley @nataliebello9 @AfshanHameedMD @IsabelleMalhame #ACCRepOB #ACCCardioOB #CardioObstetrics

Maternal diabetes during pregnancy was associated with increased risk of overall #CardiovascularDisease and specific CVD subtypes in offspring, with congenital heart disease, preterm birth, and large for gestational age mediating part of the association. ja.ma/4eNrtSN

Coronary plaque in younger women may carry a far greater prognostic signal than equivalent plaque in men. In our editorial in the Am Journal of Preventive Cardiology (doi.org/10.1016/j.ajpc…), we discuss why sex-specific interpretation of CCTA findings is essential—and why even “mild” plaque in women should prompt aggressive prevention efforts. #CardioTwitter #CCTA #WomensHeartHealth

The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology. Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association‑supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish. newsroom.heart.org/news/american-…

@CarolinaZingano Congrats Carolina!

Happy to share our results on the effects of bempedoic acid in the absence of other background lipid-lowering therapies, showing similar efficacy and safety as in the main CLEAR Outcomes trial results. academic.oup.com/eurjpc/article…

Cardiovascular disease remains the leading cause of death in women, yet traditional models miss key risks like hormonal factors, pregnancy-related conditions, and therapy differences. It’s time for precision, personalized care. frontiersin.org/journals/globa…

Grateful to my mentor @AllanLKleinMD1 for his leadership in pericardial disease and for the opportunity to learn from cases like this in a truly world class environment. @jibran_ikram

Clinical course, imaging, and hemodynamics define the transition to fixed constriction. IL-1 blockade treats inflammation, not fibrosis, but may be continued perioperatively to prevent rebound inflammation. @JACCJournals sciencedirect.com/science/articl…

In a US cohort, higher systolic #BloodPressure genetic risk was associated with new-onset #Hypertension after pregnancy, but elevated postpartum body mass index and hypertensive disorders of pregnancy were stronger risk factors. ja.ma/3NTY26s

Welcome to our APRIL 1 SPECIAL CARDIO OBSTETRICS issue of #JACCCaseReports @JACCJournals. jacc.org/journal/case-r… Full PDF here: jacc.org/doi/10.1016/S2… Thank you @MinnowWalsh for leading this special issue! @hmkyale @Justine_Turco JACC: Case Reports and Cardio-Obstetric Essentials jacc.org/doi/10.1016/j.… Imaging: Navigating the Aortopathy Dilemma in Pregnancy: Case Series Insights From a Cardiac Surgical Center jacc.org/doi/10.1016/j.… Heart Failure and Cardiomyopathies: Temporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery jacc.org/doi/10.1016/j.… Group 5 Pulmonary Hypertension Resulting From Thyrotoxicosis During Pregnancy jacc.org/doi/10.1016/j.… Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach jacc.org/doi/10.1016/j.… Calcific Constrictive Tuberculous Pericarditis in Pregnancy: A Shared Decision-Making Approach jacc.org/doi/10.1016/j.… Rhythm Disorders and Electrophysiology: Asymptomatic Complete Heart Block in Pregnancy jacc.org/doi/10.1016/j.… Fascicular Ventricular Tachycardia in Pregnancy jacc.org/doi/10.1016/j.… Vascular Medicine: Fibrosing Mediastinitis in Pregnancy: A Rare Case with Antepartum Hemoptysis and Airway Obstruction jacc.org/doi/10.1016/j.… Pregnancy-Associated Spontaneous Coronary Artery Dissection in a 32-Year-Old Woman With Postpartum Hemorrhage jacc.org/doi/10.1016/j.… Cardiometabolic: Gestational Hypertriglyceridemia Management and the Utility of Multidisciplinary Care jacc.org/doi/10.1016/j.… Congenital Heart Disease: Patent Foramen Ovale–Induced Hypoxemia Unmasked During Pregnancy jacc.org/doi/10.1016/j.… Imaging: A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin’s Lymphoma jacc.org/doi/10.1016/j.… Ischemic Heart Disease: Silent Myocardial Infarction in Pregnancy Uncovered During Routine Antenatal Echocardiographic Screening jacc.org/doi/10.1016/j.… Outcomes and Quality: Cardiac Tamponade Revealing a New Diagnosis of Malignancy: When Intervention Is the Answer jacc.org/doi/10.1016/j.… Valvular Heart Disease: Managing Pregnancy in the Presence of Rheumatic Heart Disease and Antiphospholipid Syndrome jacc.org/doi/10.1016/j.… Percutaneous Mechanical Aspiration Thrombectomy-Assisted Management of Right-Sided Infective Endocarditis During Pregnancy jacc.org/doi/10.1016/j.… Health Promotion and Preventive Cardiology: Creating a Cardio-Obstetrics Elective as a Fellow In Training jacc.org/doi/10.1016/j.… Outcomes and Quality: Early Outcomes of an Extended Postpartum Hypertension Program: Care Beyond Delivery jacc.org/doi/10.1016/j.… Valvular Heart Disease: Transcaval SESAME, LAMPOON, and Valve-in-MAC: First Experience With SESAME Outside the United States jacc.org/doi/10.1016/j.… The Next Era of Transcatheter Electrosurgery for Structural Heart Interventions jacc.org/doi/10.1016/j.… A Very Late Mitral Valve Hypoattenuated Leaflet Thickening With Significant Warfarin Response jacc.org/doi/10.1016/j.… Obstructive Hypoattenuated Leaflet Thickening in a Complex Valve-in-Valve TAVR Successfully Treated With Thrombolysis jacc.org/doi/10.1016/j.… Thrombolysis for Obstructive HALT in Complex Valve-in-Valve TAVR jacc.org/doi/10.1016/j.… Severe Aortic and Mitral Regurgitation After Blunt Chest Trauma jacc.org/doi/10.1016/j.… When Trauma Obscures the Heart: Diagnostic Blind Spots After Blunt Chest Injury jacc.org/doi/10.1016/j.… Coronary, Peripheral and Structural Interventions: Transapical Edge-to-Edge Repair for Systolic Anterior Motion in Obstructive Hypertrophic Cardiomyopathy jacc.org/doi/10.1016/j.… Management of Coronary Artery Perforations: A Stepwise, Case-Based Review From a High-Volume Center jacc.org/doi/10.1016/j.… Post-Myocardial Infarction Ventricular Septal Defect Percutaneous Closure jacc.org/doi/10.1016/j.… Atypical Presentation of Mycotic Coronary Artery Aneurysm jacc.org/doi/10.1016/j.… Laser-Assisted OPN Technique for Recalcitrant Multilayer In-Stent Restenosis: A Systematic Approach jacc.org/doi/10.1016/j.… Percutaneous Rescue With Sequential Second-Device Usage for Left Atrial Appendage Perforation During Amulet Implantation jacc.org/doi/10.1016/j.… Imaging: High-Output Heart Failure Associated With Arteriovenous Fistula jacc.org/doi/10.1016/j.… Heart Failure and Cardiomyopathies: Hemodialysis Access–Related High-Output Heart Failure: From Mechanisms to Multidisciplinary Management jacc.org/doi/10.1016/j.… Imaging: “Flying Saucer”–Like Morphology in Infective Endocarditis Arising on a Stenotic Mitral Valve jacc.org/doi/10.1016/j.… Purulent Pericarditis Complicated With Cardiac Tamponade, Multiorgan Failure, and Constrictive Pericarditis jacc.org/doi/10.1016/j.… Primary Cardiac Lymphoma Presenting With Chest Pain jacc.org/doi/10.1016/j.… Rhythm Disorders and Electrophysiology: Combined Lead Extraction and Leadless VDD Pacemaker Implantation in d-TGA Patient After Senning Procedure jacc.org/doi/10.1016/j.… Leadless Pacing and the Emerging Era of Combined Procedures in Adult Congenital Heart Disease jacc.org/doi/10.1016/j.… Propafenone Overdose Presenting With Brugada Phenocopy, QRS Widening, and Ventricular Fibrillation jacc.org/doi/10.1016/j.… 15-Year ECG Evolution of Interatrial Block and Effects of Atrial Septal Pacing jacc.org/doi/10.1016/j.… @aronisMD @JACabreraCardio @MiChen__ @aabha_divya @sarano_maurice @Miho_Fukui_ @ErikaHuttce @Nishaki1 @ChrissyMD2000 @ACHDocTMoe @M_Pompeu_Sa_MD @jsaef1 @JTSaxon @AndreaScotti21 @Kentso987 @TagliariPaula @m_taramasso @SyedZaidMD

Huge congratulations to my mentor @AllanLKleinMD1 for this year’s Distinguished Scientist Award (Clinical Domain). Very well deserved. @ACCinTouch @CleClinicHVTI @NBE_96 @ASE360

@AllanLKleinMD1 @CleClinicHVTI @ACCinTouch @NBE_96 @ASE360 Congratulations, Dr Klein! So well deserved!

It was an honor and privilege to receive the 2026 ACC distinguished scientist award in the clinical domain. I want to personally thank my colleagues, friends and family for their encouragement and support @CleClinicHVTI @ACCinTouch @NBE_96 @ASE360

The #PCSK9 inhibitor evolocumab ↘️ the risk of a first major CV event in patients w/ diabetes without known significant atherosclerosis, according to a prespecified subgroup analysis of the VESALIUS-CV trial, presented during a LBCT session at #ACC26. 🔗 bit.ly/3PBZqLo

🆕 #ACC26 Late-Breaking Trial 👇 Ez-PAVE: Lowering LDL-C to <55 mg/dL in patients with #ASCVD reduced the rate of major cardiovascular events by one-third. Want the full results? Keep reading ➡️ bit.ly/414OLeG #cvPrev

GoFreshRx: Home-Delivered DASH Groceries Improve BP and LDL-C in Black Adults With Hypertension Find out more and follow for ACC's full meeting coverage of the latest science from #ACC26 👉 bit.ly/4sLphiO #cvPrev #CardioX

PCSK9 inhibitors transformed secondary prevention— but what about primary prevention? #VESALIUS-CV evaluates evolocumab in patients without established ASCVD. Could this expand who we treat—and when? ➡️ Key results: evolocumab⤵️ CV events in this high risk primary prevention study! 56% 💃🏻 92% White #ACC26 #Lipids #CvPrev @JAMACardio 📎 jamanetwork.com/journals/jama/…

From @JAMA_current: Among adults with high-risk #diabetes and elevated LDL cholesterol, evolocumab combined with statins reduced rates of major cardiovascular events compared to statin alone. #ACC26 @ACCinTouch ja.ma/3PzQRki

Now in @ehj_ed #EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, + postmenopausal 👭 using hormone therapy) Paper here: academic.oup.com/eurheartj/adva…

Presented at #ACC26: Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results: nejm.org/doi/full/10.10… Editorial: Paving the Road toward Targeted Lipid Lowering nejm.org/doi/full/10.10… @ACCinTouch

@drahulchowdhary @ACCinTouch Very proud of you!

Was supposed to be a 4-hour flight from Cleveland.. Turned into a 15-hour journey 😅 But finally made it to New Orleans for my first ever cardiology conference! Presenting at ACC 2026 @ACCinTouch Grateful for the journey! Let’s go 🚀 #Cardiology #ACC26 #usmle #research